A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

Conditions: Chronic Heart Failure Interventions: Drug: Sacubitril and Valsartan Tablets 97mg/103mg; Drug: Entresto (Sacubitril and Valsartan Tablets 97mg/103mg) Sponsors: Viatris Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06266988

Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials